A Historical Cohort Study on the Efficacy of Glucocorticoids and Riboflavin Among Patients with Late-onset Multiple Acyl-CoA Dehydrogenase Deficiency

BACKGROUND: Late-onset multiple acyl-CoA dehydrogenase deficiency (MADD) is the most common type of lipid storage myopathies in China. Most patients with late-onset MADD are well responsive to riboflavin. Up to now, these patients are often treated with glucocorticoids as the first-line drug because...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin-Yi, Wang, Zhi-Qiang, Wang, Dan-Ni, Lin, Min-Ting, Wang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799539/
https://www.ncbi.nlm.nih.gov/pubmed/26830983
http://dx.doi.org/10.4103/0366-6999.173438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799539/
https://www.ncbi.nlm.nih.gov/pubmed/26830983
http://dx.doi.org/10.4103/0366-6999.173438

Ejemplares similares